Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$0.56 - $1.2 $15,380 - $32,959
27,466 New
27,466 $29,000
Q2 2022

Aug 16, 2022

SELL
$0.75 - $1.33 $48,934 - $86,777
-65,246 Closed
0 $0
Q1 2022

May 17, 2022

SELL
$1.09 - $1.83 $20,617 - $34,614
-18,915 Reduced 22.47%
65,246 $85,000
Q4 2021

Feb 15, 2022

BUY
$1.63 - $2.83 $82,613 - $143,432
50,683 Added 151.39%
84,161 $138,000
Q3 2021

Nov 16, 2021

SELL
$2.45 - $3.45 $102,059 - $143,716
-41,657 Reduced 55.44%
33,478 $88,000
Q2 2021

Aug 16, 2021

BUY
$3.3 - $5.02 $132,874 - $202,130
40,265 Added 115.47%
75,135 $257,000
Q1 2021

May 18, 2021

SELL
$4.29 - $9.94 $603,856 - $1.4 Million
-140,759 Reduced 80.15%
34,870 $176,000
Q4 2020

Feb 17, 2021

BUY
$2.41 - $5.63 $176,638 - $412,645
73,294 Added 71.62%
175,629 $825,000
Q3 2020

Nov 17, 2020

BUY
$0.97 - $4.08 $78,302 - $329,353
80,724 Added 373.53%
102,335 $405,000
Q2 2020

Aug 17, 2020

SELL
$0.92 - $1.29 $9,557 - $13,401
-10,389 Reduced 32.47%
21,611 $22,000
Q1 2020

May 15, 2020

BUY
$0.75 - $1.81 $14,536 - $35,081
19,382 Added 153.61%
32,000 $38,000
Q4 2019

Feb 14, 2020

SELL
$1.29 - $1.69 $29,831 - $39,081
-23,125 Reduced 64.7%
12,618 $19,000
Q3 2019

Nov 14, 2019

BUY
$1.37 - $1.7 $9,451 - $11,728
6,899 Added 23.92%
35,743 $56,000
Q2 2019

Aug 15, 2019

SELL
$1.4 - $2.47 $10,824 - $19,098
-7,732 Reduced 21.14%
28,844 $46,000
Q1 2019

May 16, 2019

BUY
$1.83 - $2.38 $1,478 - $1,923
808 Added 2.26%
36,576 $67,000
Q4 2018

Feb 15, 2019

BUY
$1.98 - $3.01 $70,820 - $107,661
35,768 New
35,768 $71,000
Q1 2018

May 15, 2018

SELL
$3.15 - $4.16 $268,276 - $354,294
-85,167 Closed
0 $0
Q4 2017

Feb 15, 2018

BUY
$3.07 - $4.68 $208,523 - $317,879
67,923 Added 393.89%
85,167 $262,000
Q3 2017

Nov 14, 2017

BUY
$4.24 - $5.06 $73,114 - $87,254
17,244
17,244 $77,000

Others Institutions Holding EVGN

# of Institutions
1
Shares Held
117K
Call Options Held
0
Put Options Held
0

About Evogene Ltd.


  • Ticker EVGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,202,000
  • Market Cap $69.6M
  • Description
  • Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...
More about EVGN
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.